| Literature DB >> 35865627 |
Ziqian Cheng1,2, Jingyun Su1,2, Kai Zhang3, Huiyi Jiang4, Bingjin Li1,2.
Abstract
Depression has an alarmingly high prevalence worldwide. A growing body of evidence indicates that environmental factors significantly affect the neural development and function of the central nervous system and then induce psychiatric disorders. Early life stress (ELS) affects brain development and has been identified as a major cause of depression. It could promote susceptibility to stress in adulthood. Recent studies have found that ELS induces epigenetic changes that subsequently affect transcriptional rates of differentially expressed genes. The epigenetic modifications involved in ELS include histone modifications, DNA methylation, and non-coding RNA. Understanding of these genetic modifications may identify mechanisms that may lead to new interventions for the treatment of depression. Many reports indicate that different types of ELS induce epigenetic modifications of genes involved in the neurotransmitter systems, such as the dopaminergic system, the serotonergic system, the gamma-aminobutyric acid (GABA)-ergic system, and the glutamatergic system, which further regulate gene expression and ultimately induce depression-like behaviors. In this article, we review the effects of epigenetic modifications on the neurotransmitter systems in depression-like outcomes produced by different types of ELS in recent years, aiming to provide new therapeutic targets for patients who suffer from depression.Entities:
Keywords: depression; early life stress; epigenetics; methylation; neurotransmitter systems
Year: 2022 PMID: 35865627 PMCID: PMC9294154 DOI: 10.3389/fcell.2022.929732
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
Summary of different types of ELS-induced epigenetic changes in neurotransmitter system-related genes in animal models mentioned in this review.
| No. | Gene name | Animal | Model | Period | Tissue | Neurotransmitter system | Biological function | Reference |
|---|---|---|---|---|---|---|---|---|
| 1 |
| C57BL/6N female mice | Maternal separation coupled with social isolation | 3 h daily from PND 1 to PND 14 | VTA; NAc | Dopaminergic system |
|
|
| 2 |
| Pregnant Wistar rats | Utero glucocorticoids exposure | Gestation day 18 and gestation day 19 | NAc | Dopaminergic system | Cell number and dopamine level↓; |
|
| After morphine administration: | ||||||||
|
| Pregnant adult Sprague–Dawley rats | Maternal deprivation | 3 h daily from PND 1 to PND 14 | NAc | Dopaminergic system | microRNA-9↓→DRD2↑→stress sensitivity↑ |
| |
| 3 |
| C57BL/6 mice | Short-term separation stress; long-term separation stress | Short-term: 3 h daily from PND 14 to PND 16; long-term: 3 h daily from PND 1 to PND 21 | HP | Dopaminergic system | Short-term stress: |
|
| long-term stress: | ||||||||
| 4 |
| Wild type and HDAC5+/− offspring | Early social isolation; early social threat | Early social isolation: 30 min daily from PND 14 to PND 21; early social threat: 30 min daily from PND 14 to PND 21 | Dorsal striatum | Dopaminergic system | Susceptible to social isolation-induced adverse effects↑ |
|
| 5 |
| Male Sprague–Dawley rats | Maternal deprivation | 24 h at PND 9 | VTA | Dopaminergic system | Transcription of |
|
| 6 |
| Sprague–Dawley rats | Neonatal maternal separation | 3 h a day from PND 1 to PND 14 | VTA; SN | Dopaminergic system |
|
|
| 7 |
| BALB/cJ mice | Maternal separation | 3 h a day from PND 2 to PND 15 | Forebrain neocortical | Serotoninergic system |
|
|
| 8 |
| Serotonin transporter knockout rats | Repeated and prolonged maternal separation | 180 min daily from PND 2 to PND 14 | CeA | Serotoninergic system |
|
|
| 9 |
| C57BL/6N mice | Maternal immune activation | First 12.5 days of pregnancy | HP | Serotoninergic system | The binding of acH3 and acH4 histones to |
|
| 10 |
| C57, DBA mice | Maternal separation and early weaning | Maternal separation: 4 h daily from PND 2 to PND 5; 8 h daily from PND 6 to PND 16; PND 17 starts early weaning | mPFC | Glutamatergic system |
|
|
| 11 |
| BALB/c mice | Utero bisphenol A exposure | Gestation day 0 to gestation to 19 | HP | Glutamatergic system |
|
|
Note: Drd1a, dopamine receptor D1; DARPP-32, dopamine- and cAMP-regulated neuronal phosphoprotein; HDAC5, histone acetylation enzyme 5; AKAP5, A-kinase anchoring protein 5; Drd2, dopamine D2 receptor; 5-HT2CR, serotonin type 2C receptor; TH, tyrosine hydroxylase; Crf, corticotropin-releasing factor receptor type 1; SERT, serotonin transporter; Grin1, NMDA R1 receptor; Grin2b, NMDA receptor 2b subunit; ID3, DNA-binding protein inhibitor ID-3; NAc, nucleus accumbens; VTA, ventral tegmental area; HP, hippocampus; SN, substantia nigra; CeA, central amygdala; Crf, corticotropin-releasing factor; 5-TT, serotonin transporter; ELS, early life stress; EWcp, centrally projecting Edinger–Westphal nucleus; mPFC, medial prefrontal cortex; ELS, early life stress; CpG, cytosine–phosphate–guanine; PND, postnatal day; DNAm, DNA methylation. The up arrow indicates the increase in expression or related behavior, the down arrow indicates the decrease in expression or related behavior, and the rightward arrow indicates mediated relationships.
FIGURE 1Different types of ELS-induced epigenetic modifications contribute to susceptibility to depression in adults. Drd1a, dopamine receptor D1; Drd2, dopamine D2 receptor; Drd3, dopamine D3 receptor; DARPP-32, dopamine- and cAMP-regulated neuronal phosphoprotein; TH, tyrosine hydroxylase; 5-HT1AR, serotonin type 1A receptor; 5-HT2CR, serotonin type 2C receptor; 5-HT3AR, serotonin type 3A receptor; SERT, serotonin transporter; TPH2, tryptophan hydroxylase 2; Grin1, NMDA R1 receptor; Grin2b, NMDA receptor 2b subunit; CRF, corticotropin-releasing factor.